“CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19”. E Conference Zone (March 4, 2024): 34–35. Accessed January 18, 2026. https://econferencezone.org/index.php/ecz/article/view/2743.